Inspire Medical Systems INSP
Revenue per employee
1,333 employees as of 2025/FY (+7.0% YoY). Revenue per employee is total revenue divided by headcount — a rough productivity gauge, not a per-worker pay figure.
Management team
Background
Mr. Herbert, our founder, has served as our Chief Executive Officer and President and as a member of our Board since November 2007. Mr. Herbert, President and Chief Executive Officer, Inspire Medical Systems, Inc. (since 2007 when he founded the Company) and held management positions in product development, clinical research, sales, marketing, and healthcare reimbursement at Medtronic plc, a medical equipment development company (1996 - 2007). Education: B.S., Electrical Engineering, North Dakota State University and M.B.A., University of St. Thomas.
Background
Carlton W. Weatherby has served as Chief Strategy and Growth Officer since December 2024, and served as our Chief Strategy Officer from July 2023 to December 2024. Prior to this, he served as Vice President and General Manager of Medtronic's Spine & Biologics Business since 2021. Medtronic is a medical technology company. Prior to this, Mr. Weatherby served as Vice President of Strategic Sales and held various roles in corporate development since joining Medtronic in 2011. Mr. Weatherby received his B.A. in Human Biology from Stanford University and his M.B.A. from Harvard Business School.
Background
Bryan K. Phillips has served as our Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary since January 2021. From December 2019 to January 2021, Mr. Phillips served as Chief Legal Officer of Cerevel Therapeutics Holdings, Inc., a publicly traded clinical-stage biopharmaceutical company that researches and develops therapies intended to treat central nervous system disorders. Previously, he held various roles over a 14-year period at Surmodics, Inc., a publicly traded medical technology company, including its Senior Vice President, Legal and Human Resources, General Counsel, and Secretary. Mr. Phillips also previously served as patent counsel at Guidant Corporation's Cardiac Rhythm Management Group (now part of Boston Scientific). He began his legal career at a Minneapolis-based intellectual property law firm and earned a B.S. in mechanical engineering from the University of Kansas and a J.D. from the University of Minnesota Law School.
Background
On January 9, 2026, the Board of Directors of the Company appointed Mr. Buchholz as interim Chief Financial Officer and designated him as the Company's interim principal financial officer and interim principal accounting officer through the filing of the Company's 2025 10-K. Rick Buchholz has served as Chief Financial Officer since May 2014. Prior to joining Inspire, Mr. Buchholz served as the Chief Financial Officer, Secretary, and Treasurer at superDimension, Ltd., a medical device manufacturer (which was acquired by Covidien plc in 2012), from 2006 to 2013. Mr. Buchholz holds a B.B.A. from the University of Wisconsin, Eau Claire and is a Certified Public Accountant (inactive).
Background
Mr. Ellis. has served as a member of our Board since July 2019. Mr. Ellis, Medtronic plc and its subsidiary, Medtronic, Inc., a global medical technology company: Executive Vice President, Global Operations, Information Technology and Facilities & Real Estate (June 2016 - December 2016); Executive Vice President and Chief Financial Officer, Medtronic, Inc. (2014 - 2016); Senior Vice President and Chief Financial Officer, Medtronic, Inc. (2005 - 2014); Vice President, Corporate Controller and Treasurer, Medtronic, Inc. (1999 - 2005). Other Public Boards: The Toro Company (since 2006); Hill-Rom Holdings, Inc. (2017 - 2021) and Itamar Medical Ltd. (2007 - 2017). Education: B.S., Accounting, University of S. Dakota and Certified Public Accountant (inactive)
Background
Mr. McCormick has served as a member of our Board since January 2017. Mr. McCormick, Chief Financial Officer, Aldevron, LLC, a technology company specializing in the manufacture of plasmid DNA, mRNA and proteins (2020 - 2022, several months after Aldevron was acquired by Danaher Corporation); Held executive management roles at various public and private medical device companies (2009 - 2015), including as Chief Financial Officer, Tornier N.V., a global orthopedic company (2012 - 2015 when Tornier merged with Wright Medical Group, Inc.) and Held various management positions at Medtronic plc, including in corporate development and finance (1992 - 2009). Other Public Boards: Nevro Corp. (since 2014); Entellus Medical, Inc. (2014 - 2018) and Surmodics, Inc. (2015 - 2020). Education: B.S., Accounting, Arizona State University; M.B.A., University of Minnesota's Carlson School of Management and Certified Public Accountant (inactive).
Background
Mr. Mead has served as a member of our Board since July 2008. Mr. Mead, Chief Executive Officer and President, HeartFlow, Inc., a digital health company transforming how heart disease is diagnosed and treated (2019 - 2021); Chief Executive Officer and President, Beaver-Visitec International, Inc., a surgical device developer and manufacturer (2016 - 2019) and Partner, Kleiner Perkins Caufield & Byers, a venture capital investment firm (2005 - 2016). Other Public Boards: Pulmonx Corporation, (since 2010), Chairman since 2019; Inari Medical Inc. (2021 - 2025); Intersect ENT, Inc., (2007 - 2022) and HeartFlow (2019 - 2021). Education: B.A., Lafayette College and M.B.A., University of Southern California.
Background
Ms. Broader has served as a member of our Board since October 2020. Ms. Broader, Chief Executive Officer and President, Chico's FAS, Inc., a fashion retailer (2015 - 2019); Walmart Inc., a multinational retail company (2009 - 2015): President and Chief Executive Officer, Walmart Europe, Middle East and Sub-Saharan Africa region (2014 - 2015); President and Chief Executive Officer, Walmart Canada Corp. (2011 - 2014); Chief Merchandising Officer, Walmart Canada Corp. (2010 - 2011); Senior Vice President, Sam's Club, a division of Walmart (2009 - 2010). Other Public Boards: Loblaw Companies Limited (since 2022); Dutch Bros Inc. (2021 - 2023); Chico's FAS, Inc. (2015 - 2019) and Raymond James Financial, Inc. (2008 - 2020). Education: B.A., Washington State University.
Background
Ms. Garinois-Melenikiotou has served as a member of our Board since July 2020. Ms. Garinois-Melenikiotou, The Estee Lauder Companies, a global beauty products company: Executive Vice President, Corporate Marketing (2015 - 2020); Senior Vice President, Corporate Marketing (2010 - 2014) and had a 27-year career including several senior leadership positions at Johnson & Johnson, a global manufacturer of medical devices, pharmaceutical products, and consumer packaged goods (1983 - 2010), including serving as President, J&J Consumer France, President, Global Business Unit Strategy and New Growth, and Global President, Beauty. Other Public Boards: Almirall, S.A. (2015 - 2022); Douglas Group (since 2024); Natura & Co (2021 - 2024) and Pulmonx Corporation (since 2020). Education: B.S. and M.S., Engineering, National Technical University of Athens a M.B.A., Sloan School of Mgmt. at M.I.T.
Background
Cynthia B. Burks has served as a member of our Board since July 2022. Ms. Burks, Genentech, Inc., a biotechnology company that is a member of the Roche Group: Senior Vice President and Chief People and Culture Officer (2019 - 2021); Vice President, Head of Human Resources, Genentech Research and Early Development (2015 - 2019); held various human resource management roles (2011 - 2015) and held human resource and organizational development positions in industries including media, consumer goods and technology (1999 - 2011). Other Public Boards: WD-40 Company (since 2022). Education: B.S., Finance, Marquette University; M.B.A., Thunderbird School of Global Management at Arizona State University and J.D., Univ. of San Francisco School of Law.
Background
On December 21, 2023, the Board of Directors of Inspire Medical Systems, Inc., appointed Myriam J. Curet, M.D., to the Board. Dr. Curet, Intuitive Surgical, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery: Executive Vice President and Chief Medical Officer (since 2017); Senior Vice President and Chief Medical Officer (2014 - 2017); Chief Medical Advisor (2005 - 2014); Stanford University: Clinical Professor of Surgery (since 2015); Professor (2000 - 2015); Associate Professor of Surgery, University of New Mexico (1994 - 2000); held various positions, Indian Health Service, an agency within the Department of Health and Human Services and Medical Deputy Director, Gallup Indian Medical Center in New Mexico.
Background
On July 20, 2026, the Board of Directors of Inspire Medical Systems, Inc., upon the recommendation of its Nominating and Corporate Governance Committee, appointed Michael H. Carrel to the Board, effective immediately. Mr. Carrel, age 55, has served as President, Chief Executive Officer and director of AtriCure, Inc. (NASDAQ: ATRC), a medical device company that provides solutions, treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, since November 2012. His career includes successful leadership in global organizations in healthcare and technology industries. Before joining AtriCure, Mr. Carrel was President and Chief Executive Officer of Vital Images, Inc., a publicly-traded medical imaging software company which was acquired by Toshiba Medical Systems Corporation. Prior to Vital Images, Mr. Carrel was President and CEO of Zamba Corporation, a publicly-traded technology company, and Chief Financial Officer of NextNet Wireless, Inc. Mr. Carrel served on the Board of Directors of Axonics, Inc., a publicly traded company and global leader in medical devices for incontinence therapies, from February 2019 to November 2024 (and served as Chairman of the Board beginning April 2020), before it was acquired by Boston Scientific. Mr. Carrel is also the Chair of Big Brothers Big Sisters of America and has served on the Board since 2021, and he has served on the Board of Medical Device Manufacturers Association (MDMA) since 2017 and Advamed since 2026. Mr. Carrel holds a B.S. in Accounting from Pennsylvania State University and an M.B.A. from The Wharton School at the University of Pennsylvania.
Background
Melissa J. Mann has served as our Chief People Officer since July 2024. Prior to joining Inspire, Ms. Mann spent eight years at UnitedHealth Group, a health insurance and healthcare services company, most recently serving as Senior Vice President Human Capital of Optum Health. From 2002 to 2015, Ms. Mann held various Human Resources leadership positions at Target Corporation. Ms. Mann also served in Human Resources at HealthNexis, a healthcare supply chain technology startup and was a Benefits Analyst at William M. Mercer, Inc., a global human resources consulting firm. Ms. Mann received her B.A. and M.B.A. in Human Resources Management from the University of St. Thomas, in St. Paul, Minnesota.
Background
Jason P. Kelly has served as our Chief Operations and Quality Officer since January 2025. Prior to joining Inspire, Mr. Kelly served in various operations and new product development roles at Stryker Corporation, a medical devices and equipment manufacturing company, since 2006, most recently as Vice President of Division Operations. He holds a Bachelor's degree in Manufacturing Engineering and a Diploma in Quality Management from the University of Limerick, as well as a Diploma in Mechanical Engineering from the Cork Institute of Technology.
Background
John C. Rondoni has served as our Chief Product and Innovation Officer since May 2025, and served as our Chief Technology Officer from May 2022 to May 2025. He has over 20 years of experience in the development of implantable medical devices and digital health systems. Since joining Inspire in 2008, Mr. Rondoni has served in product, clinical, and business development roles in the U.S. and internationally, including Senior Vice President, Research and Development, Vice President, Product Development, Information Security and Vice President, Product Development, Operations and Quality. Before joining Inspire, he worked on peripheral and central neuromodulation therapies at Medtronic, Inc., holding technical, project, and therapy leadership positions. At Medtronic, he led systems engineering for the development and commercial launch of the InterStim II platform. Mr. Rondoni is listed as an inventor on over 90 U.S. patents; he holds a B.S. and M.Eng. from the Massachusetts Institute of Technology.
Background
Matthew J. Osberg has served as our Chief Financial Officer since February 2026. Prior to joining Inspire, Mr. Osberg served as Executive Vice President and Chief Financial Officer at Apogee Enterprises, Inc., a publicly traded manufacturer of architectural building products and services, from 2023 to 2025. Earlier in his career, Mr. Osberg served as Chief Financial Officer at Helen of Troy Limited, a publicly traded global consumer products company, from November 2021 to April 2023 and Senior Vice President of Corporate Finance at Helen of Troy Limited from 2016 to 2021. Prior to this, he held senior finance leadership roles at Best Buy Co., Inc. and worked at Ernst & Young from 1998 to 2008. Mr. Osberg holds a bachelor's degree in accounting from Augsburg University and is a Certified Public Accountant (inactive).
From SEC filings, via Futu. Compensation is total reported pay for the most recent fiscal year on file, not base salary alone.
No comments yet — be the first to weigh in on INSP.
Sign in to join the discussion.